Abstract. We have previously demonstrated that Förster resonance energy transfer ͑FRET͒ efficiency and the relative concentration of donor and acceptor fluorophores can be determined in living cells using three-cube wide-field fluorescence microscopy. Here, we extend the methodology to estimate the effective equilibrium dissociation constant ͑K d ͒ and the intrinsic FRET efficiency ͑E max ͒ of an interacting donor-acceptor pair. Assuming bimolecular interaction, the predicted FRET efficiency is a function of donor concentration, acceptor concentration, 
Introduction
Förster resonance energy transfer ͑FRET͒ is a physical process in which a donor fluorophore molecule in the excited state transfers energy nonradiatively to an acceptor molecule ͑often also a fluorophore͒ in the ground state.
1,2 FRET occurs over distances of molecular scale ͑1 to 10 nm͒ and can thus be used to evaluate protein-protein interaction in living cells. The recent development of spectrally diverse fluorescent proteins ͑FP͒ that serve as genetically encoded donor and acceptor fluorophore tags has greatly facilitated FRET measurements in living cells. 3, 4 FRET is most appropriately quantified using the FRET efficiency, an instrument-independent index defined as the proportion of donor molecules that transfer excitation state energy to acceptor molecules. 4 In living cells expressing proteins fused with FPs, FRET efficiency can be accurately determined using donor fluorescence lifetime or sensitized acceptor emission intensity. 5 However, equating FRET efficiency with protein-protein interaction presents a challenge, as FRET efficiency is a function of multiple variables. The variables include the intracellular concentrations of donor and acceptor fluorophores ͑usually proteins fused to FPs͒, the affinity ͑i.e., the equilibrium dissociation constant K d ͒ of the interacting proteins, and the intrinsic FRET efficiency ͑E max ͒ of the donor/acceptor pair. Moreover, FRET efficiency is not linearly related to these variables with the exception of E max . Therefore, protein pairs with disparate K d values may display indistinguishable measured FRET efficiencies, while protein pairs with identical K d values may display different measured FRET efficiencies. 4 Hence, the measured FRET efficiency per se is not an appropriate estimator of the protein-protein binding affinity.
Estimation of the binding affinity is an important goal of protein-protein interaction assays. Erickson, Alseikhan, and Peterson, and Erickson et al. 6, 7 were the first to demonstrate the feasibility of using quantitative "three-cube" FRET measurements 8, 9 to estimate the relative K d of two proteins tagged with genetically encoded fluorophores expressed in living cells. However, the methodology required determination of several parameters measured from purified donor and acceptor fluorescent proteins, and detailed knowledge of the optical filter characteristics ͑e.g., the average molar extinction coefficient of donor and acceptor fluorophores over the bandwidth of the FRET cube excitation filter͒. 6, 7 Moreover, the equivalence of the fluorescent protein spectra determined in vitro and in vivo ͑i.e., a cellular context͒ was assumed.
Here, we describe a method to estimate the relative K d of two FP-tagged interacting proteins, which avoids these requirements and is performed using standard fluorescence microscopy and quantitative imaging techniques. The method was validated using an inducible FRET pair consisting of the FPs Cerulean and Venus fused to FKBP12 ͑a rapamycinbinding protein͒ and the Frb domain of FRAP1/mTOR, respectively. Upon addition of rapamycin, a complex with defined structure, stoichiometry, and affinity forms. 10 
Methods
In plasmid constructs used in this study, transcription was driven by the human cytomegalovirus promoter and the start codon was under the optimal context for translational initiation. 11 The constructs encoding monomeric ͑A206K mutation͒ Cerulean and Venus, variants of cyan fluorescent protein ͑CFP͒ and yellow fluorescent protein ͑YFP͒; respectively, have been previously described. [12] [13] [14] [15] The open reading frames ͑ORFs͒ encoding the rapamycin-binding protein FKBP12 ͑GenBank accession number U69485͒ and the Frb domain of FRAP1/mTOR ͑GenBank accession number NMគ019906; residues 2018-2114͒ were amplified using the polymerase chain reaction from rat whole brain cDNA ͑Clontech, Mountain View, California͒, and cloned into mammalian expression vectors encoding Cerulean and Venus, respectively. The linker sequence, KLRILQSTVPRARDPPVAT, in FKBP12-Cerulean and Frb-Venus fusion constructs was identical. The W2101F mutation was introduced into the Frb domain using the QuikChange® method ͑Stratagene, La Jolla, California͒. Frb W2101F was termed Frb KTF in the original description of the mutation. 16 HeLa cells ͑ATCC, Manassas, Virginia͒ suspended in minimal essential medium containing 10% bovine calf serum were plated onto glass-bottom tissue culture dishes ͑MatTek, Ashland, Massachusetts͒ and stored in a humidified atmosphere containing 5% CO 2 in air at 37°C. HeLa cells were transfected with plasmids using Lipofectamine 2000 ͑Invitro-gen, Carlsbad, California͒ for approximately 24 h. Prior to image acquisition, culture medium was replaced with phosphate buffered saline ͑PBS͒ containing 1 mM CaCl 2 and MgCl 2 . To induce heterodimerization, rapamycin ͑Biomol, Plymouth Meeting, Pennsylvania͒ was added to the PBS ͑1 M final concentration͒ at least 40 min prior to imaging.
The imaging procedure has been described. 17 Briefly, an Olympus IX-71 inverted microscope equipped with a 75-W xenon arc lamp ͑Cairn Research, Kent, United Kingdom͒, a UNIBLITZ mechanical shutter ͑Vincent Associates, Rochester, New York͒, a 60ϫ oil immersion objective ͑NA 1.4͒, a CFP filter set ͑I DD cube, the donor channel; excitation: 436± 10 nm, emitter: 480± 20 nm, dichroic: 455LP͒, a YFP filter set ͑I AA cube, the acceptor channel; excitation: 500± 10 nm, emitter: 540± 15 nm, dichroic: 520LP͒, and a FRET filter set ͑I DA cube, the FRET channel; excitation: 436± 10 nm, emitter: 540± 15 nm, dichroic: 455LP͒. Using a 12-bit cooled charge-coupled device ͑CCD͒ camera ͑Retiga Exi, Qimaging, Burnaby, British Columbia, Canada͒ and a custom IGOR Pro ͑version 5, WaveMetrics, Lake Oswego, Oregon͒ based program, three fluorescence intensity images, i.e., I DD , I DA , and I AA images of HeLa cells coexpressing Venus ͑or Venus-tagged protein͒ and Cerulean ͑or Ceruleantagged protein͒ were acquired using the I DD , I DA , and I AA filter cubes. Background fluorescence measured from untransfected cells was subtracted from all images. Images were acquired at room temperature ͑22 to 23°C͒ with exposure times of 0.1 to 1.5 s, analog gain was set to 1, and binning set to 2 ϫ 2. Fluorescence intensities were normalized to an exposure duration of 1 s. Due to the overlap of the excitation and emission spectra of Cerulean and Venus, the fluorescence intensity of the I DD , I DA , and I AA images had three potential sources: the donor fluorescence ͑I dd ͒, the sensitized acceptor emission ͑F c ͒ due to FRET, and the direct acceptor emission ͑I aa ͒. To isolate these components in each pixel of intensity images, standard procedures and formulae have been employed. 9 where I dd was donor ͑Cerulean͒ fluorescence measured using the I DD cube; F c was the FRET-induced acceptor ͑Venus͒ sensitized emission measured using the I DA cube, and I aa was the direct acceptor ͑Venus͒ fluorescence measured using the I AA cube. Equation ͑1͒ is essentially the same as described by Gordon et al. 9 and Eqs. ͑2͒ and ͑3͒ are essentially the same as described by Gordon et al. 9 and Tron et al. 19 From these equations, I aa , I dd , and F c were isolated as follows:
Previously we have demonstrated that expressing two donor-acceptor fusion FPs with differing FRET efficiencies allows us to determine: 1. the ratio of sensitized acceptor emission to donor fluorescence quenching ͑G factor͒, and 2. the ratio of donor/acceptor fluorescence intensity for equimo-lar concentrations in the absence of FRET ͑k factor͒. 17 G and k factors are constant for given donor/acceptor pairs and a particular imaging setup. Following determination of the G and k factors for the FPs Cerulean and Venus, the FRET efficiency ͑E͒ and the concentration ratio D / A of donor ͑Cer-ulean or Cerulean-tagged protein͒ and acceptor ͑Venus or Venus-tagged protein͒ fluorophore can be determined:
Note that I aa is proportional to the intracellular concentration of the acceptor, as FRET does not alter I aa . Thus we can use I aa to represent the relative acceptor concentration ͑A͒. Conversely, donor fluorescence intensity is altered by FRET ͑i.e., donor quenching͒. However, the quenched fluorescence can be numerically restored by addition of the term F c / G and the relative donor concentration ͑D͒ equated to the acceptor fluorescence intensity by normalization with the k factor. Thus,
Using three-cube fluorescence microscopy, I aa , I dd , and F c were determined on a pixel-by-pixel basis, therefore E and the D / A were also calculated on a pixel-by-pixel basis. In these experiments, the mean values of E and D / A from single cells were used for subsequent estimation of K d . Results are reported as mean Ϯ SEM.
Theory
Assuming a bimolecular interaction between donor and acceptor molecules, a formalism derived from receptor-ligand binding studies can be adopted, in which we equate the donor and acceptor molecules to receptor and ligand, respectively. In this study, the acceptor was not expressed in great excess relative to the donor, thus we did not assume that "free" acceptor concentration was approximated by total acceptor concentration ͑i.e., A͒. The situation is equivalent to binding experiments with ligand depletion:
in which D free , A free , and DA are the free ͑i.e., uncomplexed͒ donor, free acceptor, and donor-acceptor concentrations, respectively. D and A are the total donor and acceptor concentrations, respectively. The on and off rate constants are denoted k on and k off , respectively, and K d is the equilibrium dissociation constant. At equilibrium, the concentration of the donor-acceptor complex is described by the multivariate function:
͑15͒
The predicted FRET efficiency ͑E pred ͒ in a two-molecule system, as described here, is:
where DA / D is the fractional occupancy of donor with acceptor molecules, and E max is the intrinsic FRET efficiency of an interacting donor-acceptor pair. 21 Thus, combining Eqs. ͑15͒ and ͑16͒, E pred for any given D and A is:
Since A and D are measured in units of acceptor fluorescence ͑instead of concentration units͒, K d is expressed in these units as well. We can determine D, A, and E for cells expressing varying concentrations and ratios of interacting proteins fused to Cerulean and Venus ͓see Eqs. ͑7͒, ͑9͒, and ͑10͔͒. Treating D and A as independent variables, and E as the dependent variable, the free parameters K d and E max are adjusted to minimize the difference between the experimental and predicted results. Based on maximum likelihood analysis, the best estimates of K d and E max result from using the sum of the squared residual error ͑SSE͒ as the figure-of-merit function: 22, 23 
Strictly speaking, neither A nor D are true independent variables, as both are subject to experimental errors. However, as the value of c, one of the cross talk parameters ͓see Eqs. ͑3͒, ͑4͒, and ͑9͔͒ was very small ͑c = 0.0013± 0.0001͒, I aa ͑i.e., A͒ was nearly equal to I AA , thus A could be directly measured with the I AA cube. Moreover, as A was determined from the mean pixel value of I aa , photon counting errors were negligible. We thus treat A as an independent variable. The determination of the relative donor concentration D involves additional calculations ͓see Eq. ͑10͔͒. We have previously demonstrated that D / A can be measured accurately, 17 thus D was also treated as an independent variable. Another assumption was a Gaussian distribution of E residuals-a point we examine later in the manuscript.
The remaining task was to determine a method for adjusting the parameters K d and E max to find the minimum SSE ͑SSE min ͒. Although various iterative algorithms exist for curve-fitting multivariate functions, we chose the simple, but computationally intense, approach of computing the SSE for each dataset from a large matrix of hypothetical K d and E max values. The approach is feasible, because meaningful values of K d and E max are constrained. For example, E max must lie in the range 0 to 1 to be interpretable. Moreover, given the crystal structure of fluorescent proteins, we can restrict this range even more, as the beta barrel encapsulating the fluorophore residues prevents close apposition of the donor and acceptor fluorophores. Similarly, K d cannot be negative and the practical upper limit ͑that can be determined͒ is influenced by other factors ͑e.g., collisional FRET, see next͒. Computing the SSE min in this manner provides several advantages. First, since the error for a large parameter space is computed, the method is not susceptible to finding local minimums or dependent on initial parameter values. Second, the topology of the error space provides a visual clue as to parameter correlation. Third, the method facilitates generation of a "confidence interval contour" based on a critical value of SSE determined from the F distribution. 22 Projection of this elliptical contour provides estimates of parameter confidence intervals.
Results
We tested our method of K d estimation using a wellcharacterized inducible protein-protein heterodimerization system. 10, 16, 24 As shown schematically in Fig. 1͑a͒ , the protein FKBP12 has a high affinity ͑K d = 0.2 nM͒ for the cell permeable immunosuppressant, rapamycin. Subsequently, the FKBP12-rapamycin complex can bind the Frb domain of the FRAP1/mTOR protein with high affinity ͑K d =12 nM͒, thus bringing the C-termini of FKBP12 and the Frb domains into close apposition ͑ϳ15 Å͒. When expressed in HeLa cells, fluorescence of the fusion proteins FKBP12-Cerulean and Frb-Venus appeared distributed throughout the cytosolic and nuclear compartments ͑data not shown͒. As shown in Figs. 1͑b͒ and 1͑c͒ ͑left panels͒, E was negligible ͑0.008± 0.002, n = 120͒ in HeLa cells coexpressing FKBP12-cerulean and Frb-Venus, consistent with the idea that FKBP12 does not bind the Frb domain in the absence of rapamycin. 10 In a few cells expressing a high concentration of Frb-Venus ͑Ͼ5000 arbitrary fluorescence units, AFU͒, however, E was about 0.05. This was likely due to "collisional" FRET, as it also occurred when similar concentrations of Cerulean and Venus were expressed ͑data not shown͒. To avoid this issue, cells with Frb-Venus concentrations Ͼ5000 AFUs were excluded from further analysis. In addition, it has been reported that three-cube FRET measurements were prone to error when D / A fell outside the range 0.1 to 10; therefore only cells with D / A between 0.2 to 5 were chosen for further analysis. 25 Application of rapamycin to cells coexpressing FKBP12 and Frb induces formation of the FKBP12-rapamycin-Frb complex. 10, 16 Consistent with this idea, 40 min following application of a saturating concentration of rapamycin ͑1 M͒, we detected robust FRET ͓E = 0.153± 0.004, n = 248, Fig.  1͑b͒ and 1͑c͒, right panels͔ in HeLa cells coexpressing FKBP12-Cerulean and Frb-Venus. Under these conditions, all molecules of FKBP12-Cerulean should be bound to rapamycin. Thus, the trimolecular system reduces to a bimolecular system with the donor/receptor being the rapamycin-FKBP12-Cerulean complex, and the acceptor/ligand being Frb-Venus, thereby satisfying the conditions of Eqs. ͑15͒ and ͑17͒ that assume a bimolecular interaction.
To estimate the effective binding affinity ͑K d ͒ and the intrinsic FRET efficiency ͑E max ͒ of the rapamycin-FKBP12-Cerulean and Frb-Venus complex, HeLa cells were transfected with several different cDNA molar ratios, and an effort made to image a wide range of fluorescence intensities. E and D / A for FKBP12-Cerulean and Frb-Venus were determined using the three-filter cube approach following application of rapamycin ͑1 M͒. In the absence of rapamycin, E varied between about −3 to 3% in cells with Frb-Venus intensity less than 5000 AFU ͓Fig. 1͑c͒, left͒. Therefore, to increase signalto-noise ratio, seven cells with E less than 3% in the presence of rapamycin were excluded from further analysis.
We then calculated the SSE ͑n = 241͒ between the measured and predicted E using Eqs. ͑7͒, ͑17͒, and ͑18͒, custom Igor Pro-based computer program. A 448ϫ 448 array with row and column indices represented by hypothetical E max ͑0.1 to 0.4͒ and K d ͑0 to 2000 AFU͒ values, respectively, was filled with the computed SSE values for the dataset. In other words, each "pixel" in the array contained an "intensity" ͑i.e., z value͒ comprised of the SSE for the dataset computed from the corresponding K d ͑ordinate͒ and E max ͑abscissa͒. These Fig. 2 Estimation of the binding affinity between rapamycin-FKBP12-Cerulean and Frb-Venus coexpressed in HeLa cells using the least square method. ͑a͒ The sum of squared errors ͑SSE͒ between the measured and predicted FRET efficiencies were generated for a matrix of K d and E max values and plotted using a color scale. ͑b͒ Same plot as in ͑a͒ using an expanded color scale. The cross indicates the minimum of the SSE. ͑c͒ The ellipse ͑red͒ defines the 95% confidence contour of the estimated K d and E max . Projections of the contour ͑black lines͒ define the estimated 95% confidence intervals of the K d ͑ordinate͒ and E max ͑abscissa͒. ͑d͒ Plot of the measured versus predicted ͑based on the estimated K d and E max ͒ FRET efficiency with residuals shown before. ͑e͒ Distribution of the residuals. A Gaussian equation was fit ͑red line͒ to the histogram data. ͑f͒ The measured FRET efficiency plotted versus estimated free acceptor ͑Frb-Venus͒ concentration ͑in AFU͒. A bimolecular binding equation was fit to the data ͑red line͒. ͑Color online only.͒ data could be represented as an image with the SSE "intensity" coded by a color scale, as shown in Fig. 2͑a͒ ͑color online only͒, allowing visualization of the error space topology. The band of similar colors extending diagonally across the plot indicates a "trough" in the SSE and thus parameter correlation. Expanding the color scale over a narrower range of SSE values, both the gradient ͓Fig. 2͑b͔͒ and convergence to the SSE min ͑0.125, marked with a cross symbol͒ at K d = 148 AFU and E max = 0.244 become more apparent. A plot of the measured versus predicted E, and the corresponding residuals, is shown in Fig. 2͑d͒ . A histogram of the residuals is plotted in Fig. 2͑e͒ , and the resulting distribution fit with a Gaussian equation ͑solid line, p = 0.12, chi-square test͒. This result supports an assumption of maximum likelihood analysis, on which the SSE min as best estimator of K d and E max was based. 22 To generate estimated confidence limits for K d and E max , we defined a region within the SSE space that contained all combinations of K d and E max that generated SSEs not significantly different, at an arbitrarily defined level ͑e.g., P = 0.05͒, from the best-fit values. The critical value of the SSE for P = 0.05 is described by:
where n is the number of data points and F is the critical value of the F distribution for a P value of 0.05, with the number of parameters ͑p =2͒ as degrees of freedom in the numerator, and n-p degrees of freedom in the denominator. 22 The critical F value can be determined in several ways, e.g., statistical tables, numerically solving the F distribution cumulative probability function, or built-in computer functions. We used the Excel ͑Microsoft Corporation, Redmond, Washington͒ function FINV͑0.05, p , n-p͒ to determine the critical F value ͑version 6.0 of Igor Pro now includes the equivalent function, StatsInvFCDF͒. For the data illustrated in Fig. 2͑a͒ , SSE 0.05 was about 0.128, resulting in the confidence ellipse or contour ͑in red͒ illustrated in Fig. 2͑c͒ . The confidence interval for the individual parameters was calculated by projection of the confidence contour extremes onto the respective axes ͓Fig. 2͑c͒, black lines͔. Hence, the 95% confidence intervals of K d and E max were 83 to 230 AFU and 0.230 to 0.258, respectively. Note that the confidence intervals need not be symmetric around the best-fit values. The data can be plotted as E versus free acceptor concentration ͑A free ͒, thereby emulating a typical saturation binding isotherm ͓Fig. 2͑f͔͒. As mentioned earlier, E is proportional to fractional donor occupancy. A free was calculated using the formula: A free = A − DA. The data points were compared with a theoretical line generated from the previously determined E max and K d parameters according to: E = E max ϫ A free / ͑K d + A free ͒. The data points span much of the binding curve around the K d value-a prerequisite for accurate parameter estimation. It should be emphasized that the K d value cannot be derived from E versus A free relationship, as this represents a circular dependency. The main purpose of Fig. 2͑f͒ is to provide a visual data representation analogous to radioligand binding studies.
The ability to distinguish different affinities was tested by introducing a point mutation, W2101F, in the Frb domain. Previous studies indicated that the affinity between the rapamcyin-FKBP12 complex and Frb W2101F was reduced. 16 The experimental procedure used before was repeated using Frb W2101F -Venus in place of the wild-type construct. As shown in Fig. 3͑a͒ ͑upper ellipse͒, the effective K d and E max were estimated to be 492 AFU ͑95% confidence interval 292 to 775 AFU͒ and 0.255 ͑95% confidence interval 0.229 to 0.287͒, respectively. As before, we plotted the E measured from HeLa cells ͑n = 261͒ coexpressing FKBP12-Cerulean and Frb W2101F -Venus ͑in the presence of 1 M rapamycin͒ against the E pred ͓Fig. 3͑b͔͒. The residuals were also calculated ͓Fig. 3͑b͔͒ and the distribution found to be adequately described by a Gaussian equation ͑data not shown͒. Express- ing the data as a standard binding isotherm ͓i.e., E versus free acceptor concentration, Fig. 3͑c͔͒ revealed a right-shifted sigmoid curve with data points spanning the estimated K d value. Based on these data, we conclude that the affinity between rapamycin-FKBP12-Cerulean complex and Frb W2101F -Venus was significantly lower when compared with wild-type FrbVenus. This conclusion is visually evident when the 95% confidence ellipse from Fig. 2͑c͒ is superimposed on Fig. 3͑a͒ ͑lower ellipse͒. Our conclusion is consistent with the results from a rapamycin-induced transcriptional switch assay performed in yeast cells using Frb W2101F . 16 In contrast to the K d , the estimated E max for Frb W2101F was not significantly different from the wild-type Frb. Although structural changes resulting from point mutations are difficult to predict, the result is consistent with the position of the W2101F mutation within the context of the wild-type Frb crystal structure. The mutated residue lies within the Frb-rapamycin binding pocket and thus, barring dramatic long-range alterations in conformation, would not be expected to alter the position of the Frb C-terminus where the fluorescent protein is attached, and hence the intrinsic FRET efficiency ͑i.e., E max ͒.
An advantage of the FKBP12-rapamycin-Frb system, aside from being inducible, is that the absolute affinity ͑K d =12 nM͒ has been well characterized. 10 Assuming that the in-vivo and in-vitro binding affinities are comparable and the fluorescent protein tagging has a negligible effect on binding affinity, we can calibrate our system with the literature value for the wild-type Frb and estimate that the affinity between FKBP12-rapamycin and Frb W2101F in living cells to be about 40 nM ͑95% confidence interval 24 to 63 nM͒.
Discussion
We have described a simple optical method for estimating the effective affinity between two protein domains in living mammalian cells. This method was extended from a previous study in which E and D / A was determined in living cells using three-cube wide-field fluorescence microscopy. 17 Assuming a simple bimolecular interaction, E is a function of donor and acceptor concentrations ͑total, not free͒ and the parameters K d and E max . We estimated K d and E max by minimizing the SSE between the predicted and the measured E. Minimization was accomplished by generating SSE values for a matrix of hypothetical K d and E max values. From the topology, a 95% confidence contour for K d and E max was generated using a critical F value. Projection of the contour allowed assignment of estimated confidence intervals to each parameter. The method was tested by expressing an inducible FRET fusion pair consisting of FKBP12-Cerulean and Frb-Venus ͑wild-type or mutant͒ in HeLa cells. We demonstrated that when coexpressed in HeLa cells and in the presence of the heterodimerizationinducer rapamycin at the saturating concentration, FKBP12-Cerulean has a higher affinity for Frb-Venus than to the mutant Frb W2101F -Venus. This result was consistent with a report using a transcriptional switch assay based on the yeast twohybrid system. 16 Therefore, the described methodology is useful for comparing protein-protein interaction affinities based on FRET determinations in living cells.
Comparison with Other Methods
The development of our K d estimation method was inspired by the seminal work of Erickson, Alseikhan, and Peterson, and Erickson et al., 6, 7 who first demonstrated the feasibility of estimating protein-protein interaction affinity in living cells using three-cube FRET measurements. Although similar in principle, there are several factors that differentiate the two techniques. First, the method described here relies solely on conventional fluorescent microscopy and live cell measurements. The FRET efficiency, relative donor concentration, and relative acceptor concentration were determined using methods developed in a previous study. 17 The key requirement for calibrating the measurements ͑i.e., the G and k factors͒ was development of donor-acceptor pairs ͑i.e., FP fusion constructs͒ with widely differing E and known stoichiometries ͑e.g., 1:1͒. In contrast, Erickson, Alseikhan, and Peterson, and Erickson et al. 6, 7 used spectroscopic data from purified FPs and optical filters to arrive at D and A. Thus, our method requires fewer assumptions ͑e.g., equivalence of in-vitro to in-vivo derived constants͒ and is generally more accessible. Second, the method described here is based on traditional donor-based FRET efficiency measurements, whereas FRET ratio, an acceptor-based FRET index, was used in Refs. 6 and 7. Although both indices provide similar information, FRET efficiency is instrument-independent and thus comparable among different laboratories and experimental settings. Moreover, intrinsic FRET efficiency ͑E max ͒ provides the basis for limited inference about the distance between fluorophores. Third, although both methods are based on cellular fluorescence intensity measurements, our data were acquired with a cooled CCD camera ͑data for single cells represent the mean of many pixel values͒, whereas Erickson, Alseikhan, and Peterson, and Erickson et al. 6, 7 used a photomultiplier tube to measure total cellular fluorescence intensity, and thus assume a similar cell size. Fourth, we minimized SSE by examining a subset of error space topology, while Erickson, Alseikhan, and Peterson, and Erickson et al. used an iterative routine. Computing the error space topology allows estimation of a confidence contour helpful in interpreting the fitted parameters, and avoids finding the local ͑instead of global͒ minimum, which is a potential issue inherent to most iterative algorithms. The contour includes the parameter covariance in the evaluation of the confidence intervals, thus allowing more rigorous statistical comparison of the estimated parameters. 26 The color-coded error topology graphs ͓e.g., Fig. 2͑a͒ ͑color online only͔͒ provide visual indication of the correlation between K d and E max . A paradoxical consequence of parameter correlation is that nonoverlapping confidence contours can result in overlapping parameter confidence intervals. In this case, K d and/or E max significantly differ, but one cannot assign the difference to an individual parameter.
FRET efficiency can be determined using fluorescence lifetimes rather than intensities. In principle, the intrinsic FRET efficiency and fractional donor occupancy ͑by acceptor͒ are directly determined from the parameters ͑i.e., time constants and relative amplitudes͒ of a multiexponential fit to the donor fluorescence decay. 27, 28 For a bimolecular reaction, the relationship between fractional donor occupancy and free acceptor concentration would be described by a Langmuir binding isotherm, thus allowing K d determination using con-ventional analyses. However, lifetime imaging requires very expensive equipment unavailable to most laboratories, and collecting sufficient photon counts for reliable analyses can require 10 to 15 min per cell. Moreover, FRET efficiency and fractional donor occupancy determination based on FP lifetime analysis has proven more complex than anticipated. For example, linked constructs of Cerulean and Venus exhibited multiple time constants of donor fluorescence decay when only one component was predicted. 12 The reason for this discrepancy is unclear, but the phenomenon demonstrates unexpected complexity in what superficially appears to be a simple process. Whether lifetime imaging or intensity-based methods are used to estimated K d ͑based on FRET efficiency͒ will be dictated by the resources and expertise available, and the conditions and goals of the experiment. Under some circumstances, lifetime imaging is a more reliable method to quantify FRET efficiency when compared with intensity-based measurments. 27 Conversely, for FPs imaged in living cells, intensity-and lifetime-based methods produced comparable results. 5 
Factors Affecting Föster Resonance Eenergy Transfer Based Affinity Measurements
There are several factors that require consideration when using FRET to estimate affinity in living cells. First, signal-tonoise ratio is maximized when the proteins under study have both a high affinity and intrinsic FRET efficiency. Estimation of low affinity interactions is compromised by "collisional" FRET. For example, if the relative K d between two proteins is larger than ϳ5000 AFU, then donor occupancy cannot span a large range without incurring nonspecific FRET. Consequently, K d estimation based on these data will be prone to error. Based on the reported in-vitro determined K d of FKBP12-rapamycin and Frb, we estimate that a K d greater than 0.4 M will be difficult to assess unless collisional FRET efficiency can be accounted for. Maximizing intrinsic FRET efficiency helps to minimize this problem by increasing the signal above both the inherent noise floor and any collisional FRET that might occur. In this regard, two novel variants of GFP, CyPet and yPet, have been engineered to maximize FRET signals. 29 It is unclear at this time, however, whether CyPet and yPet will be superior to Cerulean and Venus for these types of studies.
Second, we assume that the mean fluorescence intensity ͑corrected for background and FRET͒ is proportional to fluorophore concentration. Ideally, each pixel would represent a constant cellular volume. With wide-field microscopy, this is unlikely, as one observes variation in fluorescence intensity within cells, even with a high NA objective ͑e.g., brighter over the nucleus, which is the thickest portion of the cell͒. Although determinations of E and D / A are not affected by this requirement, determinations of D and A are. For cells with similar morphology ͑such as HeLa cells͒, however, the mean cellular fluorescence intensity should be proportional to cellular fluorophore concentration for small soluble proteins that distribute evenly throughout the nucleus and cytoplasm. Estimation of the K d between two plasma membrane proteins or between a plasma membrane and a cytosolic protein, however, will likely present greater challenges, as the heterogeneity in concentrations and FRET efficiencies within subcellular compartments complicates interpretation. Techniques that limit the excitation to ͑multiphoton or total internal reflection fluorescence microscopy͒ or collection of light from ͑confocal microscopy͒ a smaller cellular volume should be superior under these circumstances.
Third, the K d estimation based on FRET measurement assumes that negligible fractions of donor or/and acceptor molecules bind to endogenous proteins. If this assumption does not hold, the K d value will be overestimated. However, the presence of potentially interacting endogenous proteins should not affect the assessment of the affinity change arising from a point mutation. It should be noted that K d values reported here ͑in AFUs͒ are instrument-dependent, whereas the ranking of K d values is not.
Fourth, we emphasize the need to image cells varying in both fluorescent protein concentration and D / A ratio. The former is usually accomplished by exploiting the normally occurring variations in protein expression, i.e., imaging the entire range of dim to bright cells. The latter, however, requires transfecting several different ratios ͑empirically determined͒ of donor/acceptor cDNA. Together, the two conditions are usually sufficient to generate a wide range of donor fractional occupancy-a requirement for accurate parameter estimation. An indicator of inadequate coverage of the donor fractional occupancy range is failure of the confidence ellipse to close at one end. 22 Finally, the current method is predicated on the assumption of a simple bimolecular interaction. It does not account for multiple binding affinities or energy transfer to multiple acceptors. Although a model accounting for additional complexity could be generated, the expansion of free parameters ͑and correlation between parameters͒ would increase parameter uncertainty and correlation-possibly beyond the point where meaningful parameter estimates are generated.
Utility
The use of FRET-based methods to indicate protein-protein interaction is becoming increasingly popular. However, FRET indices are primarily an indicator of proximity ͑if one ignores orientation factors͒, and any conclusions regarding proteinprotein interaction require an interpretation within this context. Thus, the ability to estimate the affinity between two proteins in living cells using FRET measurements provides an additional means to evaluate FRET experiments and make judgments as to whether biologically relevant proteinprotein interaction can be reasonably assumed from the measurements.
